ConductScience.org, home

Paper369646

Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.

Wright AD and 3 others. Br Med J, 1979. Cited by 154 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. Papers, record 369646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/369646

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
PubMed
Journal
Br Med J
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
154
iCite
Relative citation ratio, by iCite
6.99
iCite
Revised in PubMed
2019-05-01
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wright ADA D
2Barber SGS G
3Kendall MJM J
4Poole PHP H

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood GlucoseMajor topic
Diabetes MellitusMajor topic
MetoprololMajor topic
PropanolaminesMajor topic
PropranololMajor topic
Adult
Aged
Clinical Trials as Topic
Diabetes Complications
Double-Blind Method
Female
Humans
Hypertension
Male
Middle Aged

Source PubMed

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,338,679THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS.Biometrics1965https://conductscience.org/library/papers/14338679PubMed
374,494Coronary heart-disease after treatment of hypertension.Lancet1978https://conductscience.org/library/papers/74494PubMed
410,437The clinical pharmacology of beta adrenergic blocking drugs.J R Coll Physicians Lond1976https://conductscience.org/library/papers/10437PubMed
5638,477Possible metabolic side effects of beta-adrenergic blocking drugs.Br Med J1978https://conductscience.org/library/papers/638477PubMed
64,601,624Neural control of the endocrine pancreas.Physiol Rev1974https://conductscience.org/library/papers/4601624PubMed
74,163,545Effects of propranolol on the hormonal and metabolic responses to insulin-induced hypoglycaemia.Lancet1966https://conductscience.org/library/papers/4163545PubMed
84,397,807The action of beta-adrenergic blocking and stimulating agents on insulin secretion. Characterization of the type of beta receptor.Diabetologia1971https://conductscience.org/library/papers/4397807PubMed
955,840Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment.Lancet1976https://conductscience.org/library/papers/55840PubMed
106,244Metabolic effects of beta-adrenoreceptor blockers.Drugs1976https://conductscience.org/library/papers/6244PubMed
116,483Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography.J Chromatogr1976https://conductscience.org/library/papers/6483PubMed
128,184Comparison of atenolol and propranolol during insulin-induced hypoglycaemia.Br Med J1976https://conductscience.org/library/papers/8184PubMed
135,066,843Effect of adrenergic blocking agents on insulin response to glucose infusion in man.Acta Endocrinol (Copenh)1972https://conductscience.org/library/papers/5066843PubMed

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.

PMIDTitleJournalYearIn PapersSource
28,421,556Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.Drugs1992https://conductscience.org/library/papers/28421556PubMed
20,795,842Atenolol exposure and risk for development of adverse metabolic effects: a pilot study.Pharmacotherapy2010https://conductscience.org/library/papers/20795842PubMed
20,409,906Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.J Am Soc Hypertens2008https://conductscience.org/library/papers/20409906PubMed
11,324,677Beta-blockers in the management of hypertension in patients with type 2 diabetes mellitus: is there a role?Drugs2001https://conductscience.org/library/papers/11324677PubMed
10,160,080Selective versus nonselective beta adrenoceptor antagonists in hypertension.Pharmacoeconomics1995https://conductscience.org/library/papers/10160080PubMed
10,150,154Formulary considerations in selection of beta-blockers.Pharmacoeconomics1993https://conductscience.org/library/papers/10150154PubMed
8,374,845Report of the Canadian Hypertension Society Consensus Conference: 5. Hypertension and diabetes.CMAJ1993https://conductscience.org/library/papers/8374845PubMed
7,514,971The link between insulin resistance and hypertension. Effects of antihypertensive and antihyperlipidaemic drugs on insulin sensitivity.Drugs1994https://conductscience.org/library/papers/7514971PubMed
7,437,781Lack of effect of propranolol and metoprolol on glucose tolerance in maturity-onset diabetics.Br Med J1980https://conductscience.org/library/papers/7437781PubMed
7,320,989The prevention of adverse drug reactions--a potential role for pharmacists in the primary care team?J R Coll Gen Pract1981https://conductscience.org/library/papers/7320989PubMed
6,994,760A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6994760PubMed
6,992,822Atenolol v placebo in mild hypertension: renal metabolic and stress antipressor effects.Br J Clin Pharmacol1980https://conductscience.org/library/papers/6992822PubMed
6,802,160The effect of acebutolol and propranolol on the hypoglycaemic action of glibenclamide.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6802160PubMed
6,734,694Effect of oxprenolol and metoprolol on serum lipid concentration.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6734694PubMed
6,302,161Evidence for a therapeutic effect of dl-propranolol in benign and malignant insulinoma: report of three cases.J Endocrinol Invest1983https://conductscience.org/library/papers/6302161PubMed
6,144,502Effects of antihypertensive drugs on endocrine function.Drugs1984https://conductscience.org/library/papers/6144502PubMed
6,143,667Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.Eur J Clin Pharmacol1984https://conductscience.org/library/papers/6143667PubMed
6,131,004Diabetes and arterial hypertension.Diabetologia1983https://conductscience.org/library/papers/6131004PubMed
6,125,193The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6125193PubMed
6,122,552Beta-blockers and renal function.Drugs1982https://conductscience.org/library/papers/6122552PubMed

See all 35 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/369646

GET https://conductscience.org/api/papers/v1/369646/cited_by?page=2